UCB-35440

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUCB-35440
Drug Alias NameUCB-35440UCB-35440-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsArachidonate 5-lipoxygenase inhibitors
TargetsHistamine H1 receptorArachidonate 5-lipoxygenase
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A